Free Trial Free TrialFree Trial

More results...

Filter by Content types
Market profile databases
Pricing snapshots
Regulatory databases
Product category trackers
Regulatory reports
Market reports
Infographics
Market Snapshots
News analysis
Flavour & nicotine trackers
Filter by Geography
Africa
Asia
Australasia
Central America
Europe
United Kingdom
North America
United States
South America

Alerts LATEST ALERTS

  • United States House committee accuses CTP of ‘fostering uncertainty’…
  • Slovenia Consultation ends on bill to ban flavours…
  • Germany Notifications list updated…
  • Louisiana - United States Bill aims to ban all flavours bar tobacco…
  • Brazil Banned or legal? Status of e-cigs to be settled ‘this year’…
  • Germany Untaxed e-liquids seized after retailers’ transitional period ends…
  • Egypt Health ministry warns strongly against e-cigarettes…
  • Netherlands Figures show sharp rise in vaping by young people…
  • United States Juul and Altria face trial over alleged marketing of e-cigs to kids…
  • Switzerland Study reveals level of e-cig use by 15-year-olds…
  • Egypt Ramadan suggested as good opportunity to quit tobacco…
  • Egypt Senate passes bill that could place further restrictions on e-cigs…
View all
News analysis

Acting FDA chief Sharpless says the case for e-cigs is still unproven

Written by || 11th July 2019 || News analysis || FDA | Regulation and Legislation | North America United States

Acting US FDA commissioner Ned Sharpless has expressed his commitment to giving fair consideration to alternatives to smoking – but he still has doubts about vaping ...

Benefits of subscription plans:

  • Stay informed of any legal and market change in the sector that impacts your organization
  • Maximise resources by getting market and legal data analysis daily in one place
  • Make smart decisions by understanding how the regulatory and market landscape evolves
  • Anticipate risks in your decisions by monitoring regulatory changes that impact your organization

Need help?

Contact a sales representative right now and don’t wait

Email us

Related contents

Cancer Institute head Sharpless to follow Gottlieb as acting FDA chief
Sharpless keeps the FDA on its chosen path against youth vaping ‘epidemic’
FDA and the US vapour industry watching each other’s moves closely